Mirati Therapeutics, Inc.

Invesco Ltd.

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

65,657

Value ($000)

3,857

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	3,857	0.0%	65,657	12/31/2023
2023 Q3	11/13/2023	2,617	0.0%	60,068	9/30/2023
2023 Q2	8/11/2023	3,038	0.0%	84,072	6/30/2023
2023 Q1	5/12/2023	5,776	0.0%	155,359	3/31/2023
2022 Q4	2/13/2023	19,645	0.0%	433,576	12/31/2022
2022 Q3	11/14/2022	40,570	0.0%	580,908	9/30/2022
2022 Q2	8/15/2022	29,719	0.0%	442,712	6/30/2022
2022 Q1	5/16/2022	35,107	0.0%	426,989	3/31/2022
2021 Q4	2/14/2022	58,297	0.0%	397,413	12/31/2021
2021 Q3	11/15/2021	121,876	0.0%	688,914	9/30/2021
2021 Q2	8/17/2021	54,613	0.0%	338,096	6/30/2021
2021 Q1	5/17/2021	56,389	0.0%	329,180	3/31/2021
2020 Q4	2/16/2021	110,395	0.0%	502,616	12/31/2020
2020 Q3	11/16/2020	85,220	0.0%	513,220	9/30/2020
2020 Q2	8/14/2020	3,114	0.0%	27,277	6/30/2020
2020 Q1	5/15/2020	2,347	0.0%	30,536	3/31/2020
2019 Q4	2/14/2020	59,749	0.0%	463,670	12/31/2019